Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Researchers hope to recommend better intervention strategies to medical schools to address racial bias and prejudice in pain care.
The ViiV Healthcare grants are a key element of the company’s Risk to Reason HIV initiative guided by and for Black women.
Gilead, ViiV, NMAC, HRC, NBJC, GLAAD and others offer $5.5 million in grants to help community groups respond to monkeypox.
Gilead Sciences’ “Zeroing In” program helps 116 grantees boost HIV innovation, education and outreach in marginalized communities.
The weekly series of videos arrives as Gilead Sciences awards $16.6 million in grants to programs helping people aging with HIV.
Cathy Bradley, PhD, is leading a study to help spouses of cancer patients talk to employers about health insurance, paid leave, and more.
Human Rights Campaign’s Alphonso David explains how a Gilead Sciences grant will help the LGBTQ group fight HIV and promote health equity.
These 20 groups received grants from Gilead’s Racial Equity Community Impact Fund.
It’s part of a $234 million federal initiative to improve COVID-19 testing among vulnerable populations.
The results of GLAAD’s first State of HIV Stigma Study coincide with news of a $9 million Gilead grant to fight HIV in the South.
Gilead Sciences provides the funds through its TRANScend initiative; Destination Tomorrow in the Bronx distributes them.
“We must keep up momentum or else the results could be disastrous for people living with HIV.”
The newly renamed BHT Foundation has given over $3.5 million to 196 nonprofits.
The funding arrives via Gilead Sciences’ COMPASS Initiative.
The funding from the Elizabeth Taylor AIDS Foundation and Macy’s will benefit the LEAP for Girls program at GMHC.
The Cempa Talks initiative is based in Chattanooga, where more than 55 percent of people living with HIV are African American.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.